このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

The Effects of Kinesio Taping on Hallux Valgus

2026年5月13日 更新者:Muhammed Burak Örten

The Effects of Kinesio Taping on Hallux Valgus Angle, Plantar Pressure Measurements, and Foot-Related Quality of Life in Individuals With Hallux Valgus

Purpose: The purpose of this study is to evaluate the clinical, radiological, and biomechanical effects of Kinesio Taping (KT) when integrated into a standard exercise program for individuals with Hallux Valgus (HV). Hallux valgus is a progressive deformity of the first metatarsophalangeal (MTP) joint that leads to pain, functional impairment, and gait disturbances. While conservative treatments like exercises are common, the specific impact of KT on dynamic plantar pressure distribution and radiological angles requires further objective evidence.

Methods: A total of 50 participants (aged 18-65) with mild-to-moderate HV are randomized into two groups. Group 1 receives a 4-week intervention consisting of specialized Kinesio Taping applied once a week plus a daily home exercise program. Group 2 performs the same home exercise program only.

Assessments: Assessments include radiological measurements (Hallux Valgus Angle - HVA and Intermetatarsal Angle - IMA), clinical pain levels via the Visual Analog Scale (VAS), functional status via the American Orthopaedic Foot and Ankle Society (AOFAS-MTP-IP) scale, and dynamic pedobarographic analysis using the Zebris® FDM-2 system. Physical exercise capacity is also measured by the 6-Minute Walk Test (6MWT).

調査の概要

詳細な説明

Background and Rationale:

Hallux valgus (HV) is a progressive musculoskeletal deformity characterized by the lateral deviation of the great toe and medial deviation of the first metatarsal. This pathology significantly impairs the first metatarsophalangeal (MTP) joint dynamics, medial longitudinal arch structure, and load-bearing mechanisms. Clinical evidence suggests that HV leads to foot pain, functional limitations, impaired balance, and an increased risk of falls. While various conservative treatments exist, Kinesio Taping (KT) has gained popularity for providing dynamic support without restricting joint range of motion. This study was conducted to evaluate the corrective, functional, and biomechanical efficacy of KT integrated into an exercise program.

Study Design:

This study utilized a prospective, randomized, controlled, and assessor-blinded design. It was conducted in accordance with the Declaration of Helsinki and approved by the local Clinical Research Ethics Committee.

Participant Selection and Randomization:

Symptomatic individuals (VAS score ≥ 3) aged 18-65 with mild-to-moderate HV (HVA 15°-40°, IMA 9°-16°) were recruited from the physical medicine and rehabilitation outpatient clinic. Participants were excluded if they had neuromuscular diseases, previous foot surgery, acute inflammatory conditions, malignancies, or skin lesions in the application area. Randomization was performed using a web-based random sequence generator (random.org), and participants were assigned to groups via sequentially numbered, opaque, sealed envelopes to ensure allocation concealment.

Intervention Protocols:

Kinesio Taping Group (Group 1): Participants received four sessions of specialized KT (Kinesio Tex Gold®) applied once a week by a certified physician. A combined "I" and "X" strip configuration was used. The "I" strip was applied from the medial proximal phalanx to the posterior calcaneus with 50% mechanical correction tension. The "X" strip was applied over the first MTP joint to provide rotational control and support the transverse arch.

Exercise Protocol: Both groups followed a standardized 4-week home exercise program (2 sets of 10 repetitions daily). The protocol included "short foot" exercises, toe spreading, modified heel raises, and isolated toe extensions, supported by visual brochures and exercise diaries.

Control Group (Group 2): Participants performed the same 4-week exercise program without any taping intervention.

Assessment and Data Collection:

Assessments were conducted at baseline and after the 4-week intervention period.

Radiological Assessment: Hallux Valgus Angle (HVA) and Intermetatarsal Angle (IMA) were measured on standard weight-bearing anteroposterior radiographs by a blinded radiologist.

Pedobarographic Analysis: Dynamic gait and static posture analyses were performed using the Zebris® FDM-2 Pressure Analysis System. Data collection included a 10-second static stance and a 20-second barefoot dynamic gait analysis. A blinded physiotherapist processed the data using 3-region (hindfoot, midfoot, forefoot) and 7-region (medial/lateral heel, midfoot, medial/internal/lateral forefoot, and toes) protocols to determine peak maximum force and pressure distribution.

Clinical and Functional Measures: Pain intensity was recorded using the Visual Analog Scale (VAS). Functional status and foot-related quality of life were evaluated using the AOFAS-MTP-IP scale. Functional exercise capacity was measured via the 6-Minute Walk Test (6MWT) in a 10-meter standardized corridor.

Statistical Analysis:

The target sample size was determined as 50 participants (25 per group) based on a power analysis (G*Power 3.1) to achieve a power of 0.95. Data analysis was performed using R software (v4.4.1). Intragroup and intergroup comparisons were conducted using parametric (Independent and Paired Samples T-tests) or non-parametric tests (Mann-Whitney U and Wilcoxon tests) depending on the normality of data distribution. Statistical significance was set at p < 0.05.

研究の種類

介入

入学 (実際)

50

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

  • Women and men between the ages of 18-65
  • People with mild or moderate stage hallux valgus
  • People with VAS 3 and above

Exclusion Criteria:

  • Neuromuscular diseases that limit clinical exercise, uncontrolled psychiatric diseases or cognitive-cognitive disorders
  • Patients who have received physiotherapy to the foot area in the last 6 months
  • Presence of uncontrolled systemic diseases
  • Malignancy
  • Infection
  • High fever
  • Acute inflammatory rheumatic diseases
  • Acute peripheral vascular diseases
  • Patients with previous foot surgery
  • Patients with skin lesions in the foot area
  • Patients with rheumatoid arthritis
  • Patients without cooperation and compliance
  • Patients who did not agree to participate in the study
  • Patients with foot osteoarthritis
  • Patients with gouty arthritis
  • Patients allergic to kinesio tape material
  • Patients with hallux rigidus
  • Other lower extremity alignment disorders (genu varum/valgum, developmental hip dysplasia etc.)
  • People who have a history of using foot orthosis

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:独身

武器と介入

参加者グループ / アーム
介入・治療
実験的:Kinesio Taping and Exercise
While applying kinesio tape, individuals will also be given home exercises.
Kinesio taping for correcting hallux valgus deformity
Patients will do exercise for correcting hallux valgus deformity
アクティブコンパレータ:Exercise
Individuals will be given only home exercises
Patients will do exercise for correcting hallux valgus deformity

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Visual Analog Scale (VAS)
時間枠:4 weeks
A type of pain scale. It has a value between 0 and 10. A decrease in the value is associated with improvement.
4 weeks
Hallux Valgus and Intermetatarsophalengeal Angle
時間枠:4 weeks
4 weeks

二次結果の測定

結果測定
メジャーの説明
時間枠
Six Minute Walk Test
時間枠:4 weeks
4 weeks
Plantar Pressure Measurements
時間枠:4 weeks
4 weeks
Plantar Force Measurements
時間枠:4 weeks
4 weeks
American Orthopaedic Foot and Ankle Society Metatarsophalangeal - Interphalangeal Scale (AOFAS-MTP-IP)
時間枠:4 weeks
It has a value between 0 and 100. An increase in the value is associated with improvement.
4 weeks
Foot Rotation Degree
時間枠:4 weeks
4 weeks

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2024年12月25日

一次修了 (実際)

2025年12月1日

研究の完了 (実際)

2025年12月1日

試験登録日

最初に提出

2026年5月4日

QC基準を満たした最初の提出物

2026年5月13日

最初の投稿 (実際)

2026年5月15日

学習記録の更新

投稿された最後の更新 (実際)

2026年5月15日

QC基準を満たした最後の更新が送信されました

2026年5月13日

最終確認日

2026年5月1日

詳しくは

本研究に関する用語

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する